---
category: news
title: "HiberCell and Biodesix Initiate Broad Collaboration for Companion Diagnostic Discovery, Development and Commercialization"
excerpt: "Biodesix leverages multiple technologies with its proprietary artificial intelligence platform to discover, develop and commercialize diagnostic solutions for unmet clinical needs"
publishedDateTime: 2021-01-14T06:43:00Z
originalUrl: "https://apnews.com/press-release/business-wire/technology-business-corporate-news-biotechnology-drug-trials-e1214f6c93aa4ac28fabaf54b6dd37be"
webUrl: "https://apnews.com/press-release/business-wire/technology-business-corporate-news-biotechnology-drug-trials-e1214f6c93aa4ac28fabaf54b6dd37be"
type: article
quality: 0
heat: -1
published: false

provider:
  name: Associated Press
  domain: apnews.com

topics:
  - AI in Healthcare
  - AI

related:
  - title: "Tempus Announces Companion Diagnostic Collaboration With A2 Biotherapeutics"
    excerpt: "Tempus, a leader in artificial intelligence and precision medicine, today announced a strategic collaboration to develop a companion diagnostic (CDx)"
    publishedDateTime: 2021-01-14T00:05:00Z
    webUrl: "https://www.businesswire.com/news/home/20210113005824/en/Tempus-Announces-Companion-Diagnostic-Collaboration-With-A2-Biotherapeutics"
    type: article
    provider:
      name: Business Wire
      domain: businesswire.com
    quality: 2
  - title: "HiberCell and Biodesix Initiate Broad Collaboration for Companion Diagnostic Discovery, Development and Commercialization"
    excerpt: "Initial program to focus on development of a companion diagnostic for HiberCellâ€™s novel immunotherapy, Imprime PGG, to aid in patient selection across multiple oncology programs Biodesix, Inc. (Nasdaq: BDSX) today announced an agreement with HiberCell,"
    publishedDateTime: 2021-01-13T12:25:00Z
    webUrl: "https://www.morningstar.com/news/business-wire/20210113005304/hibercell-and-biodesix-initiate-broad-collaboration-for-companion-diagnostic-discovery-development-and-commercialization"
    type: article
    provider:
      name: Morningstar, Inc.
      domain: morningstar.com
    quality: 0

secured: "rQbDcA6zZTHxX9QkONyMF6RDrzA1247Xz9qRtJ3hz681yGmfa6baVEb2H9ZShGQLvSEplnDN2M5AVn1rvdCxIELD3zNUm75SRFM2kYf/in6osRb0m96z/sF5LNUFhfYhsI+L9f49dQhQ07as0f9+n3Yplo27h9LbAGNCcgukE0lwr8Azm2vX7fxr8MijDm8+jFHmI1K2c1xfSNAv/EkGuagDbpliEkhc7GqNWorQLgoSoJ71nFgXUWdAU4II9FXplFskbe3cGi7mehgxGkjPkK1iorlzLFHTXpXCvg3qOrY427Azqh1TJoCDKEsi29TNITY/vt7e6jP/kCWefrBkN39+gHOLGB0ZBXOEccRrbjI=;f9h0gkloWGfhaCrjiUqXpA=="
---

